Journals / Journal of Experimental and Clinical Medicine / 2026 / Volume: 30 Issue: 1

Mixed type Castleman’s disease with renal amyloidosis: Case report

Pages
—
Publication Date
2013-03-26
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The patient did not respond to colchicine therapy and the renal failure rapidly progressed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Castleman’s disease is a lymphoproliferative disorder and accompanying renal amyloidosis has been rarely described.
📊
Key Findings & Data:A 28 year old woman who has been followed by our unit with two years of Castleman’s disease was referred to our clinic with newly diagnosed proteinuria and renal failure.
💡
Conclusion & Impact:The patient did not respond to colchicine therapy and the renal failure rapidly progressed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Amyloidosis · Castleman’s disease · Colchicine

Abstract

Castleman’s disease is a lymphoproliferative disorder and accompanying renal amyloidosis has been rarely described. We report a case of Castleman’s disease with nephrotic syndrome secondary to amyloidosis. A 28 year old woman who has been followed by our unit with two years of Castleman’s disease was referred to our clinic with newly diagnosed proteinuria and renal failure. Renal biopsy showed amyloid deposit and the patient was treated with colchicine. The patient did not respond to colchicine therapy and the renal failure rapidly progressed.

🔖

Cite This Article

Erdem, E., Erdem, D., Arık, N., Yücel, İ. (2013). Mixed type Castleman’s disease with renal amyloidosis: Case report. Journal of Experimental and Clinical Medicine, Volume: 30 Issue: 1. https://doi.org/10.5835/jecm.omu.30.01.015

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Androulaki, A., Giaslakiotis, K., Giakoumi, X., Aessopos, A., Lazaris, A.C., 2007. Localized Castleman’s disease associated with systemic AA amyloidosis. Regression of amyloid deposits after tumor removal. Ann. Hematol. 86, 55-57.
  2. Castleman, B., Iverson, L., Menendez, V.P., 1956. Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer. 9, 822-830.
  3. Frizzera, G., Peterson, B.A., Bayrd, E.D., Goldman, A., 1985. A systemic lymphoproliferative disorder with morphologic features of Castle- man’s disaese: Clinical findings and clinicopathologic correlations in 15 patients. J. Clin. Oncol. 3, 1202-1216.
  4. Morita-Hoshi, Y., Tohda, S., Miura, O., Nara, N., 2008. An autopsy case of multisentric Castleman’s diasease associated with interstitial nephritis and secondary AA amyloidosis. Int. J. Hematol. 87, 69-74.
  5. Suneja, S., Chidambaram, M., Herzenberg, A.M., Bargman, J.M., 2009. Kidney involvement in multisentric castleman disease. Am. J. Kidney. Dis. 53, 550-554.
  6. Journal of Experimental and Clinical Medicine 30 (2013) 67-68